DEMYSTIFYING DATA SCIENCE

We all strive for great data and insights to feed into decisions that propel business’ forward. In today’s fast-spinning world we need to do that ever more quickly and cost-effectively. But when moving quickly, the research participant and their needs can be forgotten, and this can have negative consequences for data quality.

Data Protection and Privacy Compliance are becoming more ubiquitous and gaining in importance. In recent years, legislation has reacted by introducing e.g. the GDPR, the UK Data Protection Law or the California Consumer Privacy Act and associated regulations (“CCPA”). European Regulators especially have been clear that they take data privacy of their citizens very seriously, as shown in the January 2022 ruling of the Austrian courts against a website that was using Google Analytics.

Self-service data access opens up massive opportunities for your organization. But it can also open you up to major vulnerabilities and compliance risks. Keep it secure and compliant with robust, enterprise-wide data democratization. Join our Senior VP of Marketing Piet Loubser on August 25th to learn how to remove critical roadblocks to self-service data access. He’ll hand you the keys to achieving agile data governance.

The Rare Disease Cures Accelerator–Data and Analytics Platform (RDCA-DAP®) is launching a new webinar series with the goal of sharing with the community examples of the use of rare disease person-level data in drug development and regulatory decision making. The series will feature 1-hour webinars highlighting analyses that have been done in individual disease areas, how they informed drug development, and how similar approaches could be applied to common drug development issues encountered in rare diseases. After each presentation time will be allowed for discussion with a panel of Quantitative and Regulatory experts around why the solutions presented were informative, lessons learned and how similar approaches could be applied to related problems.